MOLECULAR TEMPLATES, INC.

Profile

Company Names

MOLECULAR TEMPLATES, INC.
D5 PHARMA, INC.

Addresses

111 W. COOPERATIVE WAY, SUITE 201, GEORGETOWN, TX 78626

401 CONGRESS AVE., SUITE 2950, AUSTIN, TX 78701

Phone Numbers

646-812-8007

 

Entity Type:

CORPORATION

Industry:

OTHER TECHNOLOGY, BIOTECHNOLOGY

Year Incorporated:

2009

State Incorporated:

DE

Total Amount Raised:

$9,409,621.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2013-09-19 
$7,000,000.00 
$7,000,000.00 
$0.00 
Equity 
2
2011-03-31 
$1,409,621.00 
$3,834,621.00 
$2,425,000.00 
Equity 
1
2009-03-20 
$1,000,000.00 
$2,500,000.00 
$1,500,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LOUIS 
 
BOCK 
DIRECTOR
ASCENTA THERAPEUTICS, INC.   |  MOLECULAR TEMPLATES, INC.
CASEY 
 
CUNNINGHAM 
DIRECTOR
TERAPIO CORP   |  MOLECULAR TEMPLATES, INC.   |  ABVITRO INC   |  BETA CAT PHARMACEUTICALS, INC.   |  LYRIC PHARMACEUTICALS INC.   |  GENEOS THERAPEUTICS, INC.   |  GLYSCEND, INC.   |  SEEING MEDICINES, INC.   |  TEN BAY BIO, INC.
JOE 
 
CUNNINGHAM 
DIRECTOR
D5 PHARMA, INC.   |  MILLIPEDE, INC.   |  BETA CAT PHARMACEUTICALS, INC.   |  REMEDY APPLICATIONS INC.   |  BIOSTABLE SCIENCE + ENGINEERING INC   |  CLAIRITY, INC.
STEVEN 
 
GULLANS 
DIRECTOR
NANOMR, INC.   |  ACTIVATE NETWORKS, INC.   |  MOLECULAR TEMPLATES, INC.   |  ISPECIMEN INC.   |  THYNK, INC.
STEPHEN 
 
HOWARD 
DIRECTOR
D5 PHARMA, INC.   |  MOLECULAR TEMPLATES, INC.   |  HFS LEGACY OAKS, LP   |  BASIN ACQUISITION FUND, LP   |  BASIN ACQUISITION FUND II, LP   |  BASIN CO-INVESTMENT II, LP
JASON 
 
KIM 
EXECUTIVE OFFICER
CENTER FINANCIAL CORP   |  MOLECULAR TEMPLATES, INC.   |  FRONTIER DENTAL SUPERHOLDINGS, LLC   |  MOLECULAR TEMPLATES, INC.   |  FIREFLY AEROSPACE INC.
KEVIN 
 
LALANDE 
DIRECTOR
HOSPITALISTS NOW, INC.   |  D5 PHARMA, INC.   |  TERAPIO CORP   |  SPINAL RESTORATION INC   |  ZENO CORP   |  MOLECULAR TEMPLATES, INC.   |  LDR HOLDING CORP   |  CHANRX CORP.   |  LYRIC PHARMACEUTICALS INC.   |  LAGUNA PHARMACEUTICALS, INC.   |  SANTE CAPITAL FUND, LP   |  CLAIRITY, INC.   |  SENSORIUM THERAPEUTICS, INC.   |  MOLECULAR TEMPLATES, INC.
ERIC 
 
POMA 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
D5 PHARMA, INC.   |  MOLECULAR TEMPLATES, INC.
TIMOTHY 
 
SULLIVAN 
DIRECTOR
VARIETAL DISTRIBUTION HOLDINGS LLC   |  FIDELIS SECURITY SYSTEMS INC   |  TILANA SYSTEMS CORP   |  TRUE ULTIMATE STANDARDS EVERYWHERE, INC.   |  ANCESTRY.COM INC.   |  AGQUEST FINANCIAL SERVICES INC   |  XERIS PHARMACEUTICALS INC   |  SAGE PRODUCTS HOLDINGS, LLC   |  HOME LAB, INC   |  NPULSE TECHNOLOGIES, INC.   |  COMPOUND HOLDINGS I, LLC   |  MUSTANG INVESTMENT HOLDINGS L.P.   |  MOLECULAR TEMPLATES, INC.   |  123 CAMINO CARMELITA LLC   |  NEW ENGLAND INNOVATION CENTER, LLC   |  KH ACQUISITION, LLC   |  HC GROUP HOLDINGS I, LLC   |  MDP HC HOLDINGS, LLC   |  LANAI HOLDINGS I, LLC   |  G1 THERAPEUTICS, INC.   |  MDP ACM HOLDINGS, LLC   |  SM HOLDCO, LLC   |  ARCADIA LANDING LLC   |  CAVEONIX INC.   |  SURGICAL TRAINING SIMULATORS, INC.
LARRY 
 
WITTE 
DIRECTOR
D5 PHARMA, INC.   |  MOLECULAR TEMPLATES, INC.   |  KADMON HOLDINGS, LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2014-07-02
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-09-19 
2011-04-15
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-03-31 
2009-04-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-03-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#